.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
McKinsey
Fuji
Argus Health
Merck
Johnson and Johnson
Chinese Patent Office
Cerilliant
Covington
Cantor Fitzgerald

Generated: November 22, 2017

DrugPatentWatch Database Preview

NITROLINGUAL PUMPSPRAY Drug Profile

« Back to Dashboard

What is the patent landscape for Nitrolingual Pumpspray, and when can generic versions of Nitrolingual Pumpspray launch?

Nitrolingual Pumpspray is a drug marketed by Pohl Boskamp and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has eight patent family members in eight countries.

The generic ingredient in NITROLINGUAL PUMPSPRAY is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

Pharmacology for NITROLINGUAL PUMPSPRAY

Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation

Medical Subject Heading (MeSH) Categories for NITROLINGUAL PUMPSPRAY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pohl Boskamp
NITROLINGUAL PUMPSPRAY
nitroglycerin
SPRAY, METERED;SUBLINGUAL018705-002Jan 10, 1997ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: NITROLINGUAL PUMPSPRAY

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pohl Boskamp
NITROLINGUAL PUMPSPRAY
nitroglycerin
SPRAY, METERED;SUBLINGUAL018705-002Jan 10, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for NITROLINGUAL PUMPSPRAY

Drugname Dosage Strength RLD Submissiondate
nitroglycerinSublingual Spray400 mcg/spray, 4.9 g and 12 g bottlesNitrolingual Pumpspray4/17/2012
nitroglycerinSublingual Spray400 mcg/spray, 4.9 g and 12 g bottlesNitrolingual Pumpspray8/23/2012

International Patent Family for Tradename: NITROLINGUAL PUMPSPRAY

Country Document Number Estimated Expiration
BrazilPI0908577► Subscribe
Canada2718345► Subscribe
Australia2009224968► Subscribe
Israel208151► Subscribe
European Patent Office2254552► Subscribe
Russian Federation2010142023► Subscribe
Germany202008007318► Subscribe
World Intellectual Property Organization (WIPO)2009112258► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Argus Health
Farmers Insurance
Mallinckrodt
Covington
Deloitte
Fish and Richardson
Healthtrust
QuintilesIMS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot